Results 111 to 120 of about 20,344 (273)

Sclerostin inhibits interleukin-1β-induced late stage chondrogenic differentiation through downregulation of Wnt/β-catenin signaling pathway.

open access: yesPLoS ONE, 2020
It is known that Wnt/β-catenin signaling induces endochondral ossification and plays a significant role in the pathophysiology of osteoarthritis (OA). Sclerostin is a potent inhibitor of the Wnt/β-catenin signaling pathway.
Kazuma Miyatake   +4 more
doaj   +1 more source

Genetic evidence that SOST inhibits WNT signaling in the limb [PDF]

open access: yes, 1987
SOST is a negative regulator of bone formation, and mutations in human SOST are responsible for sclerosteosis. In addition to high bone mass, sclerosteosis patients occasionally display hand defects, suggesting that SOST may function embryonically.
Collette, Nicole M.   +4 more
core   +1 more source

The Effect Of Light Compressive And Tensile Orthodontics Forces On Sclerostin And Periostin Expressions In Human Periodontal Ligament Cells: An Invitro Study [PDF]

open access: green, 2022
Nastaran Sharifi   +4 more
openalex   +1 more source

Role of bone-anabolic agents in the treatment of breast cancer bone metastases [PDF]

open access: yes, 2014
Skeletal metastases are an incurable complication afflicting the majority of patients who die from advanced breast cancer. They are most often osteolytic, characterized by net bone destruction and suppressed new bone formation. Life expectancy from first
Chirgwin, John M., Suvannasankha, Attaya
core   +1 more source

Aplidin (plitidepsin) is a novel anti-myeloma agent with potent anti-resorptive activity mediated by direct effects on osteoclasts [PDF]

open access: yes, 2019
Despite recent progress in its treatment, Multiple Myeloma (MM) remains incurable and its associated bone disease persists even after complete remission.
Atkinson, Emily G.   +7 more
core   +1 more source

Associations of sclerostin with carotid artery atherosclerosis and all-cause mortality in Chinese patients undergoing maintenance hemodialysis

open access: yesBMC Nephrology, 2018
Background Previous clinical studies found inconsistent relationship between circulating sclerostin levels and treatment outcome in patients undergoing maintenance hemodialysis (MHD).
Aiqun Chen   +6 more
doaj   +1 more source

Reversal of loss of bone mass in old mice treated with mefloquine [PDF]

open access: yes, 2018
Aging is accompanied by imbalanced bone remodeling, elevated osteocyte apoptosis, and decreased bone mass and mechanical properties; and improved pharmacologic approaches to counteract bone deterioration with aging are needed.
Allen, Matthew R.   +8 more
core   +1 more source

Serum Osteocalcin, Sclerostin and Lipocalin-2 Levels in Adolescent Boys with Obesity over a 12-Week Sprint Interval Training [PDF]

open access: gold, 2023
Marit Salus   +8 more
openalex   +1 more source

Osteocyte isolation and culture methods. [PDF]

open access: yes, 2016
The aim of this paper is to present several popular methods for in vitro culture of osteocytes and osteocyte cell lines. Osteocytes are located extremely suitably within the calcified bone matrix to sense mechanical signals, and are equipped with a ...
Bakker, A.D.   +5 more
core   +1 more source

The role of sclerostin in knee osteoarthritis and its relation to disease progression

open access: yesThe Egyptian Journal of Internal Medicine, 2019
Background Osteoarthritis (OA) is a common joint disease especially in aging population and is characterized by progressive degeneration of articular cartilage, osteophyte formation, and subsequent joint space narrowing.
Amina B Eldin   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy